BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18672194)

  • 1. Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure.
    Radauceanu A; Ducki C; Virion JM; Rossignol P; Mallat Z; McMurray J; Van Veldhuisen DJ; Tavazzi L; Mann DL; Capiaumont-Vin J; Li M; Hanriot D; Zannad F
    J Card Fail; 2008 Aug; 14(6):467-74. PubMed ID: 18672194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients.
    Lin YH; Lin LY; Wu YW; Chien KL; Lee CM; Hsu RB; Chao CL; Wang SS; Hsein YC; Liao LC; Ho YL; Chen MF
    Clin Chim Acta; 2009 Nov; 409(1-2):96-9. PubMed ID: 19747906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis.
    Jordán A; Roldán V; García M; Monmeneu J; de Burgos FG; Lip GY; Marín F
    J Intern Med; 2007 Sep; 262(3):385-92. PubMed ID: 17697160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodeling markers.
    Giansante C; Fiotti N; Di Chiara A; Altamura N; Wasserman S; Fioretti P; Guarnieri G
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):602-7. PubMed ID: 17667031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
    Yang YJ; Zhang X; Zhu WL; Huang Y
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum levels of proinflammatory cytokines and biomarkers of matrix remodeling in never-treated patients with familial hypercholesterolemia.
    El Messal M; Beaudeux JL; Drissi A; Giral P; Chater R; Bruckert E; Adlouni A; Chapman MJ
    Clin Chim Acta; 2006 Apr; 366(1-2):185-9. PubMed ID: 16280123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of adipocytokines and extracellular matrix activity in heart failure patients with high B-type natriuretic peptide.
    Ho YL; Lin YH; Lee CM; Hsu RB; Ting HT; Chou NK; Chao CL; Wang SS; Hsu HC; Chen MF
    Clin Biochem; 2009 Sep; 42(13-14):1407-12. PubMed ID: 19560452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?
    Collier P; Watson CJ; Voon V; Phelan D; Jan A; Mak G; Martos R; Baugh JA; Ledwidge MT; McDonald KM
    Eur J Heart Fail; 2011 Oct; 13(10):1087-95. PubMed ID: 21719449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
    Lieber CS; Weiss DG; Paronetto F;
    Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenomedullin and endothelin-1 are related to inflammation in chronic heart failure.
    Gombos T; Förhécz Z; Pozsonyi Z; Wallentin S; Papassotiriou J; Kunde J; Morgenthaler NG; Jánoskuti L; Prohászka Z
    Inflamm Res; 2009 Jun; 58(6):298-305. PubMed ID: 19212702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein in chronic heart failure: a new predictor of survival.
    Celik T; Iyisoy A; Celik M; Yuksel UC; Kardesoglu E
    Int J Cardiol; 2009 Jul; 135(3):396-7. PubMed ID: 18501446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
    Gonçalves FM; Jacob-Ferreira AL; Gomes VA; Casella-Filho A; Chagas AC; Marcaccini AM; Gerlach RF; Tanus-Santos JE
    Clin Chim Acta; 2009 May; 403(1-2):173-7. PubMed ID: 19254704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and inflammatory process in patients with atrial fibrillation: the role of left atrium distension.
    Tousoulis D; Zisimos K; Antoniades C; Stefanadi E; Siasos G; Tsioufis C; Papageorgiou N; Vavouranakis E; Vlachopoulos C; Stefanadis C
    Int J Cardiol; 2009 Aug; 136(3):258-62. PubMed ID: 18657327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased myocardial collagen turnover in patients with progressive cardiac conduction disease.
    Bozkaya YT; Aydin HH; Celik HA; Kayikcioglu M; Payzin S; Kultursay H; Aydin M; Yesil M; Can LH; Hasdemir C
    Pacing Clin Electrophysiol; 2008 Oct; 31(10):1284-90. PubMed ID: 18811809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state.
    Förhécz Z; Gombos T; Borgulya G; Pozsonyi Z; Prohászka Z; Jánoskuti L
    Am Heart J; 2009 Oct; 158(4):659-66. PubMed ID: 19781428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: an independent predictor of mortality.
    Frantz S; Störk S; Michels K; Eigenthaler M; Ertl G; Bauersachs J; Angermann CE
    Eur J Heart Fail; 2008 Apr; 10(4):388-95. PubMed ID: 18343723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling.
    Dahl CP; Husberg C; Gullestad L; Waehre A; Damås JK; Vinge LE; Finsen AV; Ueland T; Florholmen G; Aakhus S; Halvorsen B; Aukrust P; Oie E; Yndestad A; Christensen G
    Circ Heart Fail; 2009 Nov; 2(6):624-32. PubMed ID: 19919988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease.
    Bolton CE; Stone MD; Edwards PH; Duckers JM; Evans WD; Shale DJ
    Chron Respir Dis; 2009; 6(2):81-7. PubMed ID: 19411568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.